<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is the major risk factor for oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>5-Aminlevulinic acid-induced photodynamic therapy and <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation have been shown to be effective for ablating <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, but a comparative trial of these two modalities has not been reported </plain></SENT>
<SENT sid="2" pm="."><plain>AIMS: To compare photodynamic therapy and <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation for the ablation of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A total of 68 patients (54 male, 14 female; median age 61) with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> were randomized to photodynamic therapy (n = 34) or <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation (n = 34) </plain></SENT>
<SENT sid="4" pm="."><plain>Photodynamic therapy was performed using 5-aminlevulinic acid (30 mg/kg) and red light </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="17" ids="49474,49475">Argon</z:chebi> plasma coagulation was administered at a power setting of 65 W </plain></SENT>
<SENT sid="6" pm="."><plain>Multiple treatment sessions were performed, with follow-up to 24 months </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> patients showed a macroscopic reduction in the area of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This was greatest in the <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation group with 33 of 34 (97%) ablated, compared with 17 of 34 (50%) in the photodynamic therapy group; in the remainder, there was a reduction in the length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (median 50%, range: 5-90) </plain></SENT>
<SENT sid="9" pm="."><plain>Buried glands were found in 24% of photodynamic therapy patients, and in 21% of <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation patients </plain></SENT>
<SENT sid="10" pm="."><plain>The median follow-up is 12 months (range: 6-24) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Photodynamic therapy and <z:chebi fb="17" ids="49474,49475">argon</z:chebi> plasma coagulation are both effective for ablating <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="17" ids="49474,49475">Argon</z:chebi> plasma coagulation appears more effective than photodynamic therapy, but the impact of both on <z:mp ids='MP_0002038'>carcinoma</z:mp> development requires larger studies with long-term follow-up </plain></SENT>
</text></document>